Skip to main content
Veterinary Medicines

T61 šķīdums injekcijām

Authorised
  • Embutramide
  • Mebezonium iodide
  • Tetracaine hydrochloride

Product identification

Medicine name:
T61 šķīdums injekcijām
Active substance:
  • Embutramide
  • Mebezonium iodide
  • Tetracaine hydrochloride
Target species:
  • Dog
  • Cattle
  • Horse
  • Pig
  • Cat
  • Pigeon
  • Mink
  • Hamster
  • Guinea pig
  • Mouse
  • Rat
  • Rabbit
Route of administration:
  • Intravenous use
  • Intracardiac use
  • Intrapulmonary use

Product details

Active substance and strength:
  • Embutramide
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Mebezonium iodide
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tetracaine hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cattle
    • Horse
    • Pig
  • Intracardiac use
    • Dog
  • Intrapulmonary use
    • Dog
    • Cat
    • Pigeon
    • Mink
    • Hamster
    • Guinea pig
    • Mouse
    • Rat
    • Rabbit
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AX50
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/02/1429
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 11/07/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."